AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1977012 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheal tube (ETT) insertion
Number of subjects: 110
Study 418637 — intervention group
Group type: EXPERIMENTAL
Intervention: Single contrast upper gastrointestinal radiography
Number of subjects: 100
Study 418637 — intervention group
Group type: EXPERIMENTAL
Intervention: Double contrast upper gastrointestinal radiography
Number of subjects: 100
Study 418637 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of single and double contrast examinations
Number of subjects: 100
Study 418637 — intervention group
Group type: COMPARATOR
Intervention: Endoscopy
Number of subjects: 100
Study 31954847 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoenergetic feeding (12.5-15 kcal•kg‐1•d‐1)
Number of subjects: 83
Study 31954847 — intervention group
Group type: COMPARATOR
Intervention: Euenergetic feeding (25-30 kcal•kg‐1•d‐1)
Number of subjects: 83
Study 31063679 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended antibiotics (72 hours of perioperative antibiotics)
Number of subjects: 102
Study 31063679 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative antibiotics only (short antibiotics)
Number of subjects: 102
Study 31063679 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 102
Study 27252076 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise for 3 months
Number of subjects: 40
Study 27252076 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 40
Study 25844322 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam 62.5 mg BID
Number of subjects: 0
Study 25844322 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam 125 mg BID
Number of subjects: 0
Study 25844322 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam 250 mg BID
Number of subjects: 0
Study 25844322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24424561 — intervention group
Group type: EXPERIMENTAL
Intervention: 80-kilovolt (peak) protocol with hybrid iterative reconstruction (HIR) (P2)
Number of subjects: 60
Study 24424561 — intervention group
Group type: COMPARATOR
Intervention: 120-kilovolt (peak) protocol with filtered back projection (P1)
Number of subjects: 60
Study 23022090 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time three-dimensional echocardiography
Number of subjects: 53
Study 19577288 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Supreme
Number of subjects: 35
Study 19577288 — intervention group
Group type: COMPARATOR
Intervention: Z100
Number of subjects: 35
Study 17602037 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane in sitting position
Number of subjects: 48
Study 17602037 — intervention group
Group type: COMPARATOR
Intervention: Desflurane in supine position
Number of subjects: 48
Study 17602037 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined analysis of both positions
Number of subjects: 48
Study 15385115 — intervention group
Group type: EXPERIMENTAL
Intervention: HER-2/neu overexpression
Number of subjects: 361
Study 15385115 — intervention group
Group type: EXPERIMENTAL
Intervention: Response to first-line chemotherapy (CR + PR)
Number of subjects: 361
Study 15385115 — intervention group
Group type: EXPERIMENTAL
Intervention: No response to first-line chemotherapy (SD + PD)
Number of subjects: 361
Study 12161948 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk matrix identification for medical personnel
Number of subjects: 0
Study 12161948 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological risk assessment
Number of subjects: 0
Study 12161948 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical and allergic risk assessment
Number of subjects: 0
Study 12161948 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual handling of patients
Number of subjects: 0
Study 12161948 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress factor consideration
Number of subjects: 0
Study 9862847 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) therapy
Number of subjects: 548
Study 9862847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 548
Study 1671380 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg)
Number of subjects: 878
Study 1671380 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (25 mg) with weight loss diet
Number of subjects: 878
Study 1671380 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (25 mg) with low sodium/high potassium diet
Number of subjects: 878
Study 1671380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 878
Study 6868218 — intervention group
Group type: EXPERIMENTAL
Intervention: Emepronium bromide/flavoxate
Number of subjects: 20
Study 6868218 — intervention group
Group type: COMPARATOR
Intervention: Emepronium bromide
Number of subjects: 20
Study 31505542 — intervention group
Group type: EXPERIMENTAL
Intervention: l-DOPA
Number of subjects: 7
Study 31505542 — intervention group
Group type: EXPERIMENTAL
Intervention: dextroamphetamine
Number of subjects: 7
Study 31505542 — intervention group
Group type: COMPARATOR
Intervention: amantadine
Number of subjects: 7
Study 29565228 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline
Number of subjects: 42
Study 29565228 — intervention group
Group type: COMPARATOR
Intervention: Imipenem-cilastatin
Number of subjects: 42
Study 29071873 — intervention group
Group type: EXPERIMENTAL
Intervention: 6X+6 strategy (6 cores in the suspected region and another 6 in the systematic prostate)
Number of subjects: 262
Study 29071873 — intervention group
Group type: COMPARATOR
Intervention: 12+2X method (12 cores in the systematic prostate and 2 in the suspected region)
Number of subjects: 262
Study 29071873 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 262
Study 25127251 — intervention group
Group type: EXPERIMENTAL
Intervention: Theatre intervention
Number of subjects: 477
Study 25127251 — intervention group
Group type: COMPARATOR
Intervention: Tutoring
Number of subjects: 477
Study 25127251 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 477
Study 22816536 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-chamber ICD or CRT-D devices with high rate cutoff (MADIT-RIT-Arm B)
Number of subjects: 1500
Study 22816536 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection enhancements with long delay (MADIT-RIT-Arm C)
Number of subjects: 1500
Study 22816536 — intervention group
Group type: COMPARATOR
Intervention: Standard programming (MADIT-RIT-Arm A)
Number of subjects: 1500
Study 21205505 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg/day
Number of subjects: 746
Study 21205505 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 1.2 mg/day
Number of subjects: 746
Study 21205505 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride 8 mg/day
Number of subjects: 746
Study 18940392 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher urinary D‐chiro‐inositol excretion
Number of subjects: 15
Study 18940392 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher urinary myo‐ to D‐chiro‐inositol ratio
Number of subjects: 15
Study 18940392 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary D‐chiro‐inositol
Number of subjects: 15
Study 18940392 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary myo‐inositol
Number of subjects: 15
Study 15781505 — intervention group
Group type: EXPERIMENTAL
Intervention: naloxone 0.25 microg . kg(‐1) . h(‐1)
Number of subjects: 46
Study 15781505 — intervention group
Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 46
Study 12535037 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal block using bupivacaine 0.15% with ketamine 0.5 mg x kg‐1 (n = 30)
Number of subjects: 60
Study 12535037 — intervention group
Group type: COMPARATOR
Intervention: Dorsal nerve block of the penis with bupivacaine 0.5% (n = 30)
Number of subjects: 60
Study 10395629 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (20 U injected into the internal anal sphincter on each side of the anterior midline)
Number of subjects: 50
Study 10395629 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin ointment (0.2 percent applied twice daily for six weeks)
Number of subjects: 50
Study 10395629 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (crossover patients)
Number of subjects: 50
Study 9332460 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based combination chemotherapy (vindesine and cisplatin, mitomycin, vindesine and cisplatin, etoposide and cisplatin alternating with vindesine and mitomycin)
Number of subjects: 203
Study 9332460 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based combination chemotherapy (EP/VM arm)
Number of subjects: 203
Study 9332460 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based combination chemotherapy (MVP and EP/VM arms)
Number of subjects: 203
Study 9332460 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy
Number of subjects: 203
Study 8228364 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-particle aerosol (LPA) administration of bivalent cold‐adapted influenza A vaccine
Number of subjects: 198
Study 8228364 — intervention group
Group type: COMPARATOR
Intervention: Nose drops (ND) administration of bivalent cold‐adapted influenza A vaccine
Number of subjects: 198
Study 8228364 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-particle aerosol (LPA) administration
Number of subjects: 198
Study 8228364 — intervention group
Group type: COMPARATOR
Intervention: Nose drops (ND) administration
Number of subjects: 198
Study 3777408 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 30
Study 3777408 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane
Number of subjects: 30
Study 3777408 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 30
Study 3777408 — intervention group
Group type: COMPARATOR
Intervention: Halothane, Enflurane, Isoflurane
Number of subjects: 30
Study 30064627 — intervention group
Group type: EXPERIMENTAL
Intervention: DECADE brochures (A+D group)
Number of subjects: 87
Study 30064627 — intervention group
Group type: COMPARATOR
Intervention: Control group (A group)
Number of subjects: 87
Study 27101256 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session computer-delivered cognitive bias modification for interpretation biases (CBM-I) for anxiety sensitivity (AS)
Number of subjects: 0
Study 24512909 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab plus Azathioprine
Number of subjects: 239
Study 24512909 — intervention group
Group type: COMPARATOR
Intervention: Infliximab monotherapy
Number of subjects: 239
Study 24512909 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine monotherapy
Number of subjects: 239
Study 22571563 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypericum perforatum ointment applied twice daily for 4 weeks
Number of subjects: 10
Study 22571563 — intervention group
Group type: COMPARATOR
Intervention: Vehicle ointment applied twice daily for 4 weeks
Number of subjects: 10
Study 20976257 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise consultation
Number of subjects: 30
Study 20976257 — intervention group
Group type: COMPARATOR
Intervention: Canada's Physical Activity Guide for Youth
Number of subjects: 30
Study 18587712 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse care with nurse practitioners using flowcharts and motivational interviewing
Number of subjects: 793
Study 18587712 — intervention group
Group type: COMPARATOR
Intervention: Physician care
Number of subjects: 793
Study 15787665 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Participation (PP) and teaching programme
Number of subjects: 165
Study 15787665 — intervention group
Group type: COMPARATOR
Intervention: Standard Consultation (SC)
Number of subjects: 165
Study 11805785 — intervention group
Group type: EXPERIMENTAL
Intervention: Waters' projection
Number of subjects: 40
Study 11805785 — intervention group
Group type: COMPARATOR
Intervention: CT scanning
Number of subjects: 40
Study 10075325 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein diet
Number of subjects: 9
Study 10075325 — intervention group
Group type: COMPARATOR
Intervention: Soy protein diet
Number of subjects: 9
Study 10075325 — intervention group
Group type: COMPARATOR
Intervention: Self-selected diet
Number of subjects: 9
Study 10075325 — intervention group
Group type: COMPARATOR
Intervention: Casein and soy-protein diets
Number of subjects: 9
Study 7598116 — intervention group
Group type: COMPARATOR
Intervention: < 1 meal/week (referent)
Number of subjects: 21185
Study 7598116 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 fish meal/week
Number of subjects: 21185
Study 7598116 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-4 fish meals/week
Number of subjects: 21185
Study 7598116 — intervention group
Group type: EXPERIMENTAL
Intervention: >= 5 fish meals/week
Number of subjects: 21185
Study 7598116 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega 3 fatty acid intake
Number of subjects: 21185
Study 7598116 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific types of fish
Number of subjects: 21185
Study 1672488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 1672488 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (200 mg)
Number of subjects: 80
Study 1672488 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (200 micrograms)
Number of subjects: 80
Study 1672488 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (150 mg)
Number of subjects: 80
Study 6920332 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole prophylaxis
Number of subjects: 133
Study 31770051 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal (ID) injection of 9 µg hemagglutinin (HA)/strain
Number of subjects: 80
Study 31770051 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular (IM) injection of 15 µg HA/strain
Number of subjects: 80
Study 31770051 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal (ID) injection of 9 µg HA/strain
Number of subjects: 80
Study 30850406 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac output-guided haemodynamic therapy algorithm for intravenous fluid and inotropic drug administration during and in the 6 hours following surgery (n=368)
Number of subjects: 734
Study 30850406 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n=366)
Number of subjects: 734
Study 29021285 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (511 IU/d from diet and a cholecalciferol supplement) for 10 weeks
Number of subjects: 24
Study 25665498 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-tailored, pedometer-based PA intervention (booklet, non-blinded pedometer, Internet link for tailored advice)
Number of subjects: 274
Study 25665498 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention components)
Number of subjects: 274
Study 25665498 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-tailored, pedometer-based PA intervention
Number of subjects: 274
Study 25665498 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 274
Study 23591659 — intervention group
Group type: EXPERIMENTAL
Intervention: PCM Cervical Disc
Number of subjects: 342
Study 23591659 — intervention group
Group type: COMPARATOR
Intervention: ACDF
Number of subjects: 342
Study 20621362 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Clinical Global Impression (CGI)
Number of subjects: 50
Study 20621362 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean of at least two independent evaluations of the video CGI
Number of subjects: 50
Study 20621362 — intervention group
Group type: EXPERIMENTAL
Intervention: Video CGI
Number of subjects: 50
Study 19430307 — intervention group
Group type: EXPERIMENTAL
Intervention: AIDSVAX B/E HIV‐1 candidate vaccine
Number of subjects: 196
Study 19430307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study 17823649 — intervention group
Group type: EXPERIMENTAL
Intervention: risperidone 3 mg daily
Number of subjects: 55
Study 15592332 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (1.7 mg bergamottin)
Number of subjects: 11
Study 15592332 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg bergamottin
Number of subjects: 11
Study 15592332 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg bergamottin
Number of subjects: 11
Study 15592332 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg bergamottin
Number of subjects: 11
Study 15592332 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 11
Study 11315240 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip protector
Number of subjects: 164
Study 11315240 — intervention group
Group type: COMPARATOR
Intervention: Control (non-wearers)
Number of subjects: 164
Study 9765764 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy with or without postoperative radiotherapy
Number of subjects: 2
Study 9765764 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative chemotherapy)
Number of subjects: 2
Study 9765764 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy
Number of subjects: 2
Study 7990020 — intervention group
Group type: EXPERIMENTAL
Intervention: root planing plus a mixture of tetracycline and citric acid‐containing gel (RP + TC‐CAG group)
Number of subjects: 64
Study 7990020 — intervention group
Group type: COMPARATOR
Intervention: root planing alone (RP group)
Number of subjects: 64
Study 7990020 — intervention group
Group type: COMPARATOR
Intervention: tetracycline‐containing gel alone (TCG group)
Number of subjects: 64
Study 7990020 — intervention group
Group type: COMPARATOR
Intervention: root planing plus tetracycline‐containing gel (RP + TCG group)
Number of subjects: 64
Study 2658361 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic sclerotherapy
Number of subjects: 41
Study 2658361 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (Control)
Number of subjects: 41
Study 30428836 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (scheduled pain treatment)
Number of subjects: 95
Study 30428836 — intervention group
Group type: COMPARATOR
Intervention: Placebo (corresponding placebo treatment)
Number of subjects: 95
Study 28793003 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary drainage
Number of subjects: 240
Study 28793003 — intervention group
Group type: COMPARATOR
Intervention: No axillary drainage
Number of subjects: 240
Study 24817695 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins C (1 g) and E (400 IU)
Number of subjects: 42
Study 24817695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 23647804 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training (48 sessions over 12 weeks)
Number of subjects: 41
Study 23647804 — intervention group
Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 41
Study 20053349 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone 0.03 mg/kg/d
Number of subjects: 133
Study 20053349 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone 0.06 mg/kg/d
Number of subjects: 133
Study 20053349 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone 0.03 mg/kg/d or 0.06 mg/kg/d
Number of subjects: 133
Study 20053349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 18434455 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical skin coolant spray
Number of subjects: 92
Study 18434455 — intervention group
Group type: COMPARATOR
Intervention: Standard method (control group)
Number of subjects: 92
Study 18434455 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (study and control)
Number of subjects: 92
Study 16538125 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone hydrogel lens (lotrafilcon A lenses, Focus NIGHT & DAY)
Number of subjects: 88
Study 16538125 — intervention group
Group type: COMPARATOR
Intervention: Conventional hydrogel lenses (etafilcon A or polymacon)
Number of subjects: 88
Study 12825305 — intervention group
Group type: EXPERIMENTAL
Intervention: ephedrine-rocuronium
Number of subjects: 80
Study 12825305 — intervention group
Group type: COMPARATOR
Intervention: placebo-rocuronium
Number of subjects: 80
Study 12825305 — intervention group
Group type: EXPERIMENTAL
Intervention: ephedrine-atracurium
Number of subjects: 80
Study 12825305 — intervention group
Group type: COMPARATOR
Intervention: placebo-atracurium
Number of subjects: 80
Study 10993853 — intervention group
Group type: EXPERIMENTAL
Intervention: GR-II stent
Number of subjects: 755
Study 10993853 — intervention group
Group type: COMPARATOR
Intervention: Palmaz-Schatz stent
Number of subjects: 755
Study 8889425 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen arginine (400 mg)
Number of subjects: 120
Study 8889425 — intervention group
Group type: COMPARATOR
Intervention: Morphine sulphate (5 mg)
Number of subjects: 120
Study 8889425 — intervention group
Group type: COMPARATOR
Intervention: Morphine sulphate (10 mg)
Number of subjects: 120
Study 1797888 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (50 mg p.o. q.i.d.)
Number of subjects: 177
Study 1797888 — intervention group
Group type: EXPERIMENTAL
Intervention: DMSO (500 mg p.o. q.i.d.)
Number of subjects: 177
Study 1797888 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 177
Study 7316037 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction catheter with antibiotic irrigation
Number of subjects: 0
Study 7316037 — intervention group
Group type: COMPARATOR
Intervention: Closed suction catheter with povidone-iodine irrigation
Number of subjects: 0
Study 7316037 — intervention group
Group type: COMPARATOR
Intervention: Standard open wound care with delayed primary closure
Number of subjects: 0
Study 31794857 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management exercise program (5 sessions) + spa therapy (18 days)
Number of subjects: 123
Study 31794857 — intervention group
Group type: COMPARATOR
Intervention: Control group (spa therapy only, 18 days)
Number of subjects: 123
Study 31096309 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy (rosuvastatin)
Number of subjects: 0
Study 31096309 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 0
Study 28651338 — intervention group
Group type: EXPERIMENTAL
Intervention: TPF (docetaxel, cisplatin, 5-fluorouracil)
Number of subjects: 119
Study 28651338 — intervention group
Group type: COMPARATOR
Intervention: PF (cisplatin/5-fluorouracil)
Number of subjects: 119